An association between TP53 mutations and shorter recurrence-free survival in patients with HNSCC has been reported, while another study found that truncating TP53 mutations, but not missense mutations, were associated with worse OS and PFS, when compared to wild-type TP53 [66,67,68]. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.